Furthermore, PD‐L1 inhibitors have been reported to be effective in rare classifications of NSCLC, such as LCC and pleomorphic carcinoma.6, 7, 8. The gene discussed is CD274; the disease is leukoencephalopathy with calcifications and cysts.